作者
- Antman, E.M. (36)
- Braunwald, E. (49)
- Cannon, C.P. (25)
- Gibson, C.M. (17)
- Giugliano, R.P. (17)
- McCabe, C.H. (63)
- Morrow, D.A. (27)
- Murphy, S.A. (12)
- Sabatine, M.S. (16)
- de Lemos, J.A. (11)
|
總筆數:63
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with abedside myoglobin assay and the 12-lead electrocardiogram |
for the InTIME-II investigators;de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.; |
American Heart Journal |
2000-09-01 |
查看 |
| Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time |
Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; |
American Heart Journal |
2000-10-01 |
查看 |
| Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time |
Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; |
American Heart Journal |
2000-10-01 |
查看 |
| Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time |
Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; |
American Heart Journal |
2000-10-01 |
查看 |
| Prior aspirin users with acute non-ST-elevation coronary syndromes are atincreased risk of cardiac events and benefit from enoxaparin |
Santopinto, J.;Gurfinkel, E.P.;Torres, V.;Marcos, E.;Bozovich, G.E.;Mautner, B.;McCabe, C.H.;Antman, E.M.; |
American Heart Journal |
2001-04-01 |
查看 |
| Prior aspirin users with acute non-ST-elevation coronary syndromes are atincreased risk of cardiac events and benefit from enoxaparin |
Santopinto, J.;Gurfinkel, E.P.;Torres, V.;Marcos, E.;Bozovich, G.E.;Mautner, B.;McCabe, C.H.;Antman, E.M.; |
American Heart Journal |
2001-04-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; |
American Heart Journal |
2001-05-01 |
查看 |
| Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial |
Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial |
Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method foridentifying patients with a patent infarction-related artery afterfibrinolytic administration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Direct comparison of characteristics, treatment, and outcomes of patientsenrolled versus patients not enrolled in a clinical trial at centersparticipating in the TIMI 9 Trial and TIMI 9 Registry |
Bahit, M.C.;Cannon, C.P.;Antman, E.M.;Murphy, S.A.;Gibson, C.M.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2003-01-01 |
查看 |
| Prior peripheral arterial disease and cerebrovascular disease areindependent predictors of adverse outcome in patients with acute coronarysyndromes: Are we doing enough? Results from the Orbofiban in Patients withUnstable Coronary Syndromes-Thrombolysis In Myocardial Infarction(OPUS-TIMI) 16 study |
Cotter, G.;Cannon, C.P.;McCabe, C.H.;Michowitz, Y.;Kaluski, E.;Charlesworth, A.;Milo, O.;Bentley, J.;Blatt, A.;Krakover, R.;Zimlichman, R.;Reisin, L.;Marmor, A.;Lewis, B.;Vered, Z.;Caspi, A.;Braunwald, E.;OPUS-TIMI 16 Investigators; |
American Heart Journal |
2003-04-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction |
for the ExTRACT-TIMI 25 Investigators;Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Early initiation of lipid-lowering therapy for acute coronary syndromesimproves compliance with guideline recommendations: Observations from theOrbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial |
Smith, C.S.;Cannon, C.P.;McCabe, C.H.;Murphy, S.A.;Bentley, J.;Braunwald, E.; |
American Heart Journal |
2005-03-01 |
查看 |
| Early initiation of lipid-lowering therapy for acute coronary syndromesimproves compliance with guideline recommendations: Observations from theOrbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial |
Smith, C.S.;Cannon, C.P.;McCabe, C.H.;Murphy, S.A.;Bentley, J.;Braunwald, E.; |
American Heart Journal |
2005-03-01 |
查看 |
| Early initiation of lipid-lowering therapy for acute coronary syndromesimproves compliance with guideline recommendations: Observations from theOrbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial |
Smith, C.S.;Cannon, C.P.;McCabe, C.H.;Murphy, S.A.;Bentley, J.;Braunwald, E.; |
American Heart Journal |
2005-03-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-06-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-06-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-08-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-08-01 |
查看 |
| Association between Thrombolysis In Myocardial Infarction myocardialperfusion grade, biomarkers, and clinical outcomes among patients withmoderate- to high-risk acute coronary syndromes: Observations from theRandomized Trial to Evaluate the Relative PROTECTion against Post-PCIMicrovascular Dysfunction and Post-PCI Ischemia among Antiplatelet andAntithrombotic Agents-Thrombolysis In Myocardial Infarction 30(PROTECT-TIMI 30) |
for the TIMI Study Group;Gibson, C.M.;Kirtane, A.J.;Morrow, D.A.;Palabrica, T.M.;Murphy, S.A.;Stone, P.H.;Scirica, B.M.;Jennings, L.K.;Herrmann, H.C.;Cohen, D.J.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Evaluation of prasugrel compared with clopidogrel in patients withacute coronary syndromes: design and rationale for the TRial to assessImprovement in Therapeutic Outcomes by optimizing platelet InhibitioN withprasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) |
for the TRITON-TIMI 38 Investigators;Wiviott, S.D.;Antman, E.M.;Gibson, C.M.;Montalescot, G.;Riesmeyer, J.;Weerakkody, G.;Winters, K.J.;Warmke, J.W.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Early initiation of eptifibatide in the emergency department beforeprimary percutaneous coronary intervention for ST-segment elevationmyocardial infarction: Results of the Time to Integrilin Therapy in AcuteMyocardial Infarction (TITAN)-TIMI 34 trial |
for the TIMI Study Group;Gibson, C.M.;Kirtane, A.J.;Murphy, S.A.;Rohrbeck, S.;Menon, V.;Lins, J.;Kazziha, S.;Rokos, I.;Shammas, N.W.;Palabrica, T.M.;Fish, P.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
|
|
|
